Autism Impact Fund
VC Fund
San Francisco, United States
Autism Impact Fund is a VC fund in San Francisco focused on Health Care and Medical. Autism Impact Fund is to invest in life science breakthroughs and therapeutics, innovative service companies, and life beyond childhood.
- Total investments:
- 22
- Last investment:
- Lead investor:
- 50%
Last updated:
For AI agents: llms.txt
Industries Autism Impact Fund invests in
Stages Autism Impact Fund invests in
Countries Autism Impact Fund invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Ashok Srinivasan
|
|||
Christopher Male
|
|||
Elizabeth Horn
|
|||
Robert Sarrazin
|
|||
Brian A. O’Callaghan
|
Investment Focus
Industry
- Health Care 7 (32%)
- Medical 4 (18%)
- Hospital 3 (14%)
- Software 3 (14%)
- Child Care 3 (14%)
Stage
- Venture - Series Unknown 7 (32%)
- Seed 4 (18%)
- Series A 3 (14%)
- Series B 2 (9%)
- Funding Round 2 (9%)
Country
- United States 11 (50%)
- India 1 (5%)
- Germany 1 (5%)
- United Kingdom 1 (5%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Ashok Srinivasan
Chief Scientific Officer
|
Chief Scientific Officer | Total investments: 2 | Find email | |
|
Christopher Male
Co-Founder & Managing Partner
|
Co-Founder & Managing Partner | Total investments: 12 | Find email | |
|
Elizabeth Horn
Founding Partner
|
Founding Partner | Total investments: 0 | Find email | |
|
Robert Sarrazin
Chief Investment Officer & Managing Partner
|
Chief Investment Officer & Managing Partner | Total investments: 1 | Find email | |
|
Brian A. O’Callaghan
Co-Founder
|
Co-Founder | Total investments: 0 | Find email | |
| See all 6 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Constems-AI
|
Constems-AI is an internet-based company that focuses on the development and application of artificial intelligence technologies. The company's vision is to bring the power of AI to every business, with a particular emphasis on vision-based AI that can surpass human cognitive ability. This involves the creation of AI systems that can makedecisions or predictions based on the data fed to them. The company also places a high value on the selection and training of its employees, with a focus on agility and energy in its workforce. | $2M / Seed / Mar 11, 2026 | |
Imagine Pediatrics
|
Imagine Pediatrics is a virtual healthcare service for children with complex medical conditions. | $67M / Series B / Sep 17, 2025 | |
Cortica
|
Cortica is a rapidly growing healthcare company pioneering a unique and effective approach to treating neurodevelopmental conditions including autism spectrum disorder, speech and language delays, sensory processing disorder and other conditions that impact brain development. Harnessing insights and technologies from emerging neuroscience, Corticabrings together clinical specialists from a range of disciplines to design and deliver comprehensive care to children with developmental differences. | $80M / Nov 20, 2024 | |
|
Cortica
|
Cortica is a rapidly growing healthcare company pioneering a unique and effective approach to treating neurodevelopmental conditions including autism spectrum disorder, speech and language delays, sensory processing disorder and other conditions that impact brain development. Harnessing insights and technologies from emerging neuroscience, Corticabrings together clinical specialists from a range of disciplines to design and deliver comprehensive care to children with developmental differences. | $80M / Nov 20, 2024 | |
MARAbio
|
MARAbio is a biotech firm that works to detect and prevent severe forms of Autism. | $19.1M / Series A / Oct 07, 2024 | |
|
Cortica
|
Cortica is a rapidly growing healthcare company pioneering a unique and effective approach to treating neurodevelopmental conditions including autism spectrum disorder, speech and language delays, sensory processing disorder and other conditions that impact brain development. Harnessing insights and technologies from emerging neuroscience, Corticabrings together clinical specialists from a range of disciplines to design and deliver comprehensive care to children with developmental differences. | $75M / Series D / Apr 17, 2023 | |
SpectrumAi
|
SpectrumAi is a digital health company innovating Autism care to increase access to high-quality ABA therapy for kids on the spectrum around the world. With support from industry veterans in technology and healthcare, SpectrumAi is working with global clinical leaders in ABA therapy, parents, and payers to modernize. | $20M / Series A / Mar 16, 2023 | |
Healios
|
Founded in 2013, Healios is a leading digital healthcare technology company working to empower patients and families affected by mental and physical illnesses.Healios is pioneering how family intervention and behavioural change techniques are delivered beyond treatment team walls, to maximise patient and family outcomes. By blending the best oftechnology, specialised expertise and a personal human connection, they help patients and families develop a new level of understanding and sustain healthier habits over time. Their mission is to transform how care is delivered to help patients, families and carers effectively move forward and achieve their goals, providing a better quality of life. | $15.6M / Series B / Nov 03, 2022 | |
Floreo
|
Floreo is a virtual reality therapy system for autism, ADHD and anxiety therapy. Floreo is now used by over 100 therapy clinic businesses and school districts. We're a trail blazer for digital therapeutic reimbursement as the first VR behavioral health company w/ an approved CPT 3 reimbursement code. And we're partnered with Metato help bring Floreo VR to public schools. | $10M / Series A / Oct 28, 2022 | |
|
SpectrumAi
|
SpectrumAi is a digital health company innovating Autism care to increase access to high-quality ABA therapy for kids on the spectrum around the world. With support from industry veterans in technology and healthcare, SpectrumAi is working with global clinical leaders in ABA therapy, parents, and payers to modernize. | $9M / Seed / Jun 01, 2022 | |
| See all 22 investments → | |||
Co-Investors
Frist Cressey Ventures
4 deals together
AlbionVC
2 deals together
Anthemis
2 deals together
Difference Partners
2 deals together
Domain Associates
2 deals together
F-Prime
2 deals together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Autism Impact Fund invest in?
Autism Impact Fund invests primarily in Health Care, Medical and Hospital startups, most often at Venture - Series Unknown and Seed stage. Most of the 22 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Autism Impact Fund?
Public channels for Autism Impact Fund include LinkedIn, the website linked on this profile and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Autism Impact Fund?
The team at Autism Impact Fund includes Ashok Srinivasan (Chief Scientific Officer), Christopher Male (Co-Founder & Managing Partner) and Elizabeth Horn (Founding Partner), among 6 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
